Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Requirement in Counterpulsation (HEROIC)
NCT00445211Phase 2Terminated
- Sponsor
- Corewell Health
- Start
- Jan 2006
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in limb ischemia, thrombosis, sponsored by Corewell Health. Started Jan 2006; status: terminated.
02
Drugs
heparin
03
Conditions
limb ischemiathrombosis
Beyond the preview
Go deeper on NCT00445211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445211.